Patrick Daly

Cancer Nursing Today nonprod

Following allogeneic hematopoietic cell transplantation (HCT), conventional graft-versus-host disease (GVHD) prophylaxis with calcineurin inhibitors and methotrexate is sometimes replaced by methotrexate 5 mg/m2 on day 1, 3, 6, and 11 in patients where toxicity is a concern. Researchers evaluated the effects of omitting the day 11 administration. They found that omitting the dose lowered the risk of mucosal damage and bacterial infection, but it increased the risk of severe acute and chronic GVHD.<h3>Day 11 Methotrexate Necessary in GVHD Prevention</h3>The study, published in Transplantation and Cellular Therapy, investigated 135 retrospective cases of unrelated bone marrow transplantation at the authors&rsquo; center from 2006 to 2019. In total, 72 patients who did not receive the day 11 dose were compared with 63 patients who did receive it.Researchers reported the 4-year overall survival (OS) was 58.7%. The day-11-omitted group had worse GVHD-free, relapse-free survival (P=.01) with comparable OS (P=.11) and relapse-free survival (P=.11).In addition, the authors noted human leukocyte antigen mismatch between donor and recipient was a major risk factor for severe GVHD. Analyses of matched or mismatched subgroups found patients without the day 11 dose of <a href="https://medlineplus.gov/druginfo/meds/a682019.html" target="_blank" rel="noopener">methotrexate</a> had higher risks for severe acute and chronic GVHD.&ldquo;The omission of day 11 [methotrexate] was associated with a higher risk of severe GVHD. Therefore, the omission of the day 11 dose is not recommended,&rdquo; the authors concluded.

Omitting the Day 11 Administration in Mini-Dose Methotrexate

GVHD

Investigators found greater risk for severe acute graft-versus-host disease after omitting the day 11 dose in the mini-dose methotrexate regimen.

About Us

Editorial Policy

Authors

Advertising

eNewsletters

Contact Us

Contribute

Calendar of Events

Career Center

Blood Cancers Today

GU Oncology Now

DocWire News

MashupMD

Urban Health Today

Breast Cancer

Colorectal Cancer

GI Cancer

GU Cancer

Gynecologic Cancer Awareness Month

Gyn-Onc

Blood Cancer Awareness Month

Leukemia

Lymphoma

Myeloproliferative Neoplasms

Multiple Myeloma

Myelodysplastic Syndrome

Myelofibrosis

Sickle Cell

Hem/Onc

Professional Development

Patient Voice

Lung Cancer

Skin Cancer

Other Tumor Types

News

Treatment

More

Conferences

Calendar

CARE Award

Best Practices

Expert Interviews

Subscribe